Invesaro

Stocks Real estate IH

NYSE · Real estate

iHuman Inc. (IH)

iHuman Inc. reported revenue of $115.4M in fiscal 2025, down 8.7% from a year earlier. Net income was $13.6M, a net margin of 11.8%. Operating cash flow minus capital spending left $6.6M of free cash flow in fiscal 2025. At December 31, 2025 it held $164.6M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on April 24, 2026.

Free, no password. An email when IH files with the SEC.

Price
$1.13
-2.59% on the day · November 6, 2026
52-week range $1.10 to $2.99
Market cap
$57.8M
Revenue (FY2025)
$115.4M
-8.7% year on year
Net margin
11.8%

Key facts about iHuman Inc.

Net worth
iHuman Inc. has a market value (market cap) of $57.8M at the latest share price, and shareholders' equity of $142.3M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $115.4M (-8.7% year on year), with net income of $13.6M.
Cash flow
In fiscal 2025 operations brought in $7.3M of cash; after $701K of capital spending, free cash flow was $6.6M.
Latest report
The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on April 24, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR

What iHuman Inc. does

iHuman Inc. is registered with the SEC under industry code SIC 8200 (Services-Educational Services). Its shares trade on NYSE under the ticker IH.

Revenue and profit by year

Revenue
FY20: $81.5M $81.5M FY20FY21: $148.2M $148.2M FY21FY22: $142.9M $142.9M FY22FY23: $143.4M $143.4M FY23FY24: $126.3M $126.3M FY24FY25: $115.4M $115.4M FY25
Net income
FY20: -$5.7M -$5.7M FY20FY21: -$5.8M -$5.8M FY21FY22: $15.9M $15.9M FY22FY23: $25.5M $25.5M FY23FY24: $13.5M $13.5M FY24FY25: $13.6M $13.6M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$115.4M$9.5M$13.6M$0.05$6.6M
2024$126.3M$9.9M$13.5M$0.05$7M
2023$143.4M$22.5M$25.5M$0.09$23.3M
2022$142.9M$16.2M$15.9M$0.06$26.4M
2021$148.2M-$8.5M-$5.8M-$0.02$930K
2020$81.5M-$6.8M-$5.7M-$0.03$31.7M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Where IH ranks in Real estate

Revenue$115.4M
#150 of 232 in Real estate · Bottom 35%
Revenue growth-8.7%
#179 of 207 in Real estate · Bottom 14%
Net margin11.8%
#95 of 210 in Real estate · Top 45%
Free cash flow margin5.8%
#75 of 117 in Real estate · Bottom 36%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Real estate

Dividends

It paid out $5.6M in cash dividends, 41% of its net income.

Fiscal yearPer sharePaid outOf profit
2025n/a$5.6M41%
2024n/a$4.8M36%

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What iHuman Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 29, 2026
  2. June 29, 2026
  3. June 1, 2026
  4. April 24, 2026
    Annual report (foreign issuer) 20-F · period to December 31, 2025Revenue fell 8.7% to $115.4M versus the prior year; diluted EPS $0.05 versus $0.05.
  5. March 31, 2026
  6. December 29, 2025
  7. September 18, 2025
  8. June 26, 2025
  9. April 28, 2025
    Annual report (foreign issuer) 20-F · period to December 31, 2024Revenue fell 12% to $126.3M versus the prior year; diluted EPS $0.05 versus $0.09.
  10. March 25, 2025

Recent insider filings (Forms 3, 4 and 144): 9, the latest on July 9, 2026. Insider transactions on SEC

Insider trades

What the people running iHuman Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about IH

What does iHuman Inc. do?

iHuman Inc. is a company in the Real estate sector, listed on NYSE as IH. Its shares trade on NYSE under the ticker IH.

What is iHuman Inc.'s net worth?

iHuman Inc. has a market value (market cap) of $57.8M at the latest share price, and shareholders' equity of $142.3M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is iHuman Inc. profitable?

Yes. In fiscal 2025 it reported net income of $13.6M on revenue of $115.4M, a net margin of 11.8%.

How much revenue does iHuman Inc. make?

In fiscal 2025 iHuman Inc. reported revenue of $115.4M. That is 8.7% less than a year earlier.

When did iHuman Inc. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on April 24, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from September 29, 2026.

Similar companies

Compare IH with

Compare IH with any company

Follow IH

Get an email when iHuman Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when IH files with the SEC.

Where the numbers come from

Financial figures are the values iHuman Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.